A Study to Evaluate Safety and Tolerability of QLS-101 in NTG

Clinical trial NCT04857827 · COMPLETED

Trial details

NCT number: NCT04857827
Sponsor: Qlaris Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Normal Tension Glaucoma (NTG)

Start date: 2021-09-15
Primary completion: 2022-08-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.